US Patent 9402887 Composition for treating prostate cancer (PCa)
Patent 9402887 was granted and assigned to CureVac on August, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9402887 Composition for treating prostate cancer (PCa)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.